2026 Annual Meeting | C153 - The Handoff That Matters: Transition: Practical Pearls for Adult Neurologists Caring for Childhood-onset Disorders

Date Tuesday 04/21/26

Time 03:30 PM - 05:30 PM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Ann H. Tilton, MD, FAAN

Topic(s) Child Neurology and Developmental Neurology

Learning Objectives Participants should be able to describe current best practices for caring for adults with childhood-onset disorders, including specific disorders and their clinical features; recognize and manage the distinct complexities found in specific subspecialty areas; and formulate strategies for lifelong care of individuals with childhood-onset diseases, including differential diagnoses and recognizing the multidisciplinary needs.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Systems-based Practice, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student, Coordinator

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
03:30 PM - 03:38 PM CDT	Introduction	Why This Matters in Adult Neurology Today Ann H. Tilton, MD, FAAN
03:38 PM - 03:56 PM CDT	Speaker	Caring for adults with pediatric-onset movement disorders : pearls in practice Claudio M. De Gusmao, MD
03:56 PM - 04:14 PM CDT	Speaker	Epilepsy Beyond Pediatrics: Transition Models and Adult Care Pitfalls Danielle M. Andrade, MD
04:14 PM - 04:32 PM CDT	Speaker	Crossing the Care Continuum: A Transition Model for Adult Neurology in Childhood-Onset Neuromuscular Disorders Shaida Khan, DO
04:32 PM - 04:50 PM CDT	Speaker	Autism in Adult Neurology: Practical Strategies for Behavioral and Cognitive Care David Q. Beversdorf, MD, FAAN
04:50 PM - 05:08 PM CDT	Speaker	Genetics in the Adult Neurology Clinic: Interpreting Childhood-onset Disorders Nino Kerashvili, MD
05:08 PM - 05:30 PM CDT	Q&A	What Keeps You Up at Night? Real-world Questions in Transition Care Ann H. Tilton, MD, FAAN, Claudio M. De Gusmao, MD, Nino Kerashvili, MD, David Q. Beversdorf, MD, FAAN, Danielle M. Andrade, MD

Faculty Disclosures
David Q. Beversdorf, MD, FAAN	Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yamo pharmaceuticals. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier (Research in Autism Spectrum Disorders). The institution of Dr. Beversdorf has received research support from Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as a Case Consultant with Best Doctors.
Nino Kerashvili, MD	Dr. Kerashvili has nothing to disclose.
Danielle M. Andrade, MD	The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. The institution of Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. The institution of Dr. Andrade has received research support from Epilepsy Canada. The institution of Dr. Andrade has received research support from SynGAP Research Fund. Dr. Andrade has received publishing royalties from a publication relating to health care. Dr. Andrade has a non-compensated relationship as a Former Chair of task force on Transition with International League Against Epilepsy that is relevant to AAN interests or activities. Dr. Andrade has a non-compensated relationship as a President with Canadian League Against Epilepsy that is relevant to AAN interests or activities.
Shaida Khan, DO	Dr. Khan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB pharma. Dr. Khan has received personal compensation in the range of $500-$4,999 for serving as a Group instructor with Real CME.
Claudio M. De Gusmao, MD	Dr. DeGusmao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mendelics Genomic Analysis. Dr. DeGusmao has received personal compensation in the range of $0-$499 for serving as a Consultant for EBSCO publishing. Dr. DeGusmao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Outcome Solutions. Dr. DeGusmao has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for PTC Therapeuthics. The institution of Dr. DeGusmao has received research support from FDA.
Ann H. Tilton, MD, FAAN	Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Tilton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up to Date.

��ɫ��

��ɫ��